
PF-06648671
CAS No. 1587727-31-8
PF-06648671 ( PF6648671 )
产品货号. M12266 CAS No. 1587727-31-8
PF-06648671 (PF6648671) 是一种新型口服γ-分泌酶调节剂,正在开发用于治疗阿尔茨海默病。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥8068 | 有现货 |
![]() ![]() |
50MG | ¥28998 | 有现货 |
![]() ![]() |
100MG | ¥39690 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称PF-06648671
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述PF-06648671 (PF6648671) 是一种新型口服γ-分泌酶调节剂,正在开发用于治疗阿尔茨海默病。
-
产品描述PF-06648671 (PF6648671) is a novel oral γ-secretase modulator being developed for the treatment of Alzheimer's disease.Alzheimer Disease Phase 1 Discontinued.
-
体外实验In a cell-based assay, PF-06648671 reduces Aβ42 and Aβ40 , with concomitant increases in Aβ37 and Aβ38, without inhibiting the cleavage of Notch or other substrates.
-
体内实验PF-06648671 demonstrates reduces Aβ42 within the brain and CSF following acute oral administration in animals.
-
同义词PF6648671
-
通路Wnt/Notch/Hedgehog
-
靶点γ-secretase
-
受体γ-secretase
-
研究领域——
-
适应症——
化学信息
-
CAS Number1587727-31-8
-
分子量538.928
-
分子式C25H23ClF4N4O3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C1C(N2CCN1[C@H]([C@H]3O[C@@H](C4=CC(F)=C(Cl)C=C4C(F)(F)F)CC3)C)=CC=C(N5C=C(C)N=C5)C2=O
-
化学全称2H-Pyrido[1,2-a]pyrazine-1,6-dione, 2-[(1S)-1-[(2S,5R)-5-[4-chloro-5-fluoro-2-(trifluoromethyl)phenyl]tetrahydro-2-furanyl]ethyl]-3,4-dihydro-7-(4-methyl-1H-imidazol-1-yl)-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years